In contrast, small duct type CCA exhibits a mass-forming growth pattern and exhibits isocitrate dehydrogenase 1/2 mutations (10%-30%) and fibroblast growth factor receptor 2 (FGFR2) fusions (10%-25%), among others[10,11]. This evidence concerns the gene FGFR2 and cholangiocarcinoma.